tradingkey.logo
tradingkey.logo
Search

Franklin Genomic Advancements ETF

HELX
Add to Watchlist
41.131USD
-1.380-3.25%
Close 11-16 16:00(ET)
0.00Volume
0.00Turnover
After-hours 18:30 (ET)41.131USD-1.380-3.25%

Franklin Genomic Advancements ETF

41.131
-1.380-3.25%

Today

-3.25%

5 Days

-6.68%

1 Month

+0.02%

6 Months

+25.51%

Year to Date

+13.29%

1 Year

+18.36%

Key Figures

41.575Open
42.511Prev. Close
42.330High
41.131Low
0.00Volume
0Turnover
15.03Volume Ratio
46.22052wk High
31.24152wk Low
7.10KAvg Volume
0.34%Div Yield
0.143Est. Annual Div.
ThemeInvestment Segment
NoInverse ETF
NoLeveraged ETF
--Leverage Factor
42.971NAV
USDNAV Currency
7.08P/B
33.05Price to earnings ratio

Franklin Genomic Advancements ETF Profile

Ticker SymbolHELX
Asset ClassEquity
Fund ManagerFranklin
DomicileUS
Expense Ratio0.50%
Founded at2020-02-25
Tracking Index--
HELX was created on 2020-02-25 by Franklin. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 33.84m in AUM and 68 holdings. HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery.

Top 10 Holdings

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell

Franklin Genomic Advancements ETF News

More news coming soon, stay tuned...

FAQs

What is the current price of Franklin Genomic Advancements ETF (HELX)?

The current price of Franklin Genomic Advancements ETF (HELX) is 41.58. Market data may be delayed; please refer to the timestamp displayed on the page.

What is the 52-week high of Franklin Genomic Advancements ETF?

The 52-week high of Franklin Genomic Advancements ETF is 46.22. Please refer to the page timestamp for the latest data.

What is the 52-week low of Franklin Genomic Advancements ETF?

The 52-week low of Franklin Genomic Advancements ETF is 31.24. Please refer to the page timestamp for the latest data.

What is the NAV of Franklin Genomic Advancements ETF?

The NAV of Franklin Genomic Advancements ETF is 42.97 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.

Is Franklin Genomic Advancements ETF (HELX) a safe investment?

No investment is completely risk-free. The risk level of Franklin Genomic Advancements ETF (HELX) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.